Neurotrophin-3 Enhances the Effectiveness of Cell Therapy in Chronic Spinal Cord Injuries

Bull Exp Biol Med. 2022 May;173(1):114-118. doi: 10.1007/s10517-022-05504-4. Epub 2022 May 27.

Abstract

Neurotrophin-3 enhances the effectiveness of human olfactory ensheathing cells in improving hind limb mobility in rats with post-traumatic cysts of the spinal cord. Transplantation of olfactory ensheathing cells into spinal cord cysts reduced their size; neurotrophin-3 did not modulate this effect. Combined preparation of human olfactory ensheathing cells and neurotrophin- 3 can be used in neurosurgery for the treatment of patients with spinal cord injuries.

Keywords: cell therapy; human olfactory ensheathing cells; neurotrophin-3; olfactory mucosa; spinal cord injury.

MeSH terms

  • Animals
  • Cell Transplantation
  • Cell- and Tissue-Based Therapy*
  • Cysts* / therapy
  • Humans
  • Nerve Growth Factors / genetics
  • Nerve Regeneration
  • Neurotrophin 3* / pharmacology
  • Rats
  • Spinal Cord
  • Spinal Cord Injuries* / therapy

Substances

  • NTF3 protein, human
  • Nerve Growth Factors
  • Neurotrophin 3